Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate after ESWL for upper urinary tract stone expulsion
ChiCTR2600132718Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Zhengzhou University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of potassium citrate in Lithiasis (2 arms), sponsored by The Second Affiliated Hospital of Zhengzhou University. Primary endpoint: Stone expulsion time. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
potassium citrate
03
Conditions
Lithiasis
Beyond the preview
Go deeper on ChiCTR2600132718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132718.